EREG antibody, Unconjugated, Rabbit, Polyclonal

Product Overview

• Article Name: EREG antibody, Unconjugated, Rabbit, Polyclonal
• Biozol Catalog Number: BYT-ORB378205-IH
• Supplier Catalog Number: orb378205
• Alternative Catalog Number: BYT-ORB378205-100
• Manufacturer: Biorbyt
• Host: Rabbit
• Category: Antikörper
• Application: IHC-P, WB
• Species Reactivity: Human, Mouse, Rat
• Immunogen: KLH conjugated synthetic peptide derived from human EREG. Please contact us for the exact immunogen sequence. The peptide is available as orb12967.
• Conjugation: Unconjugated

Product Description

EREG antibody

Product Properties

• Clonality: Polyclonal
• Concentration: - 100 µg (in 200 µl): 0.5 mg/ml- 200 µg (in 400 µl): 0.5 mg/ml
• Molecular Weight: 19 kDa
• Purity: Polyclonal antibodies are purified by peptide affinity chromatography
• Form: 10 mM PBS, 0.02% sodium azide
• Target: EREG

Application Notes

• Application Dilute: IHC-P: 1:100-800, WB: 1:200-2000

Images

Immunohistochemical staining of paraffin embedded human liver cancer tissue using EREG antibody (primary antibody at 2.5 ug/ml)

Immunohistochemical staining of paraffin embedded human gastric cancer tissue using EREG antibody (primary antibody at 2.5 ug/ml)

IHC-P staining of human gastric cancer tissue using anti- EREG (dilution at 2.5 ug/ml)

Immunohistochemical staining of human prostatic cancer tissue using anti- EREG (dilution of primary antibody - 2.5 ug/ml)

IHC-P image of rat liver tissue using EREG antibody (dilution of primary antibody at 2.5 ug/ml)

Immunohistochemical staining of paraffin embedded human colon cancer tissue using anti- EREG (primary antibody at 2.5 ug/ml)

Immunohistochemical staining of paraffin embedded human colon cancer tissue using anti- EREG (primary antibody at 2.5 ug/ml)

Wesstern blot analysis of human lung cancer (lane 1), human breast cancer (lane 2), human thyroid cancer (lane 3), human endometrial cancer (lane 4), human ovarian cancer (lane 5), Hela cells (lane 6) using EREG antibody (1 ug/ml)

WB analysis of human lung cancer (lane 1), human breast cancer (lane 2), human thyroid cancer (lane 3), human endometrial cancer (lane 4), human ovarian cancer (lane 5), Hela cells (lane 6) using EREG antibody (1 ug/ml)